Full-Time

Senior Manager, Lifecycle Marketing

Posted on 9/10/2025

AgelessRx

AgelessRx

51-200 employees

Direct-to-consumer telehealth for longevity treatments

Compensation Overview

$90k - $100k/yr

Remote in USA

Remote

Category
Growth & Marketing (2)
,
Required Skills
Data Analysis
Requirements
  • 4 years of experience in marketing with a focus on lifecycle marketing (ideally through transformation, growth or rebuild)
  • Experience with marketing automation platforms, CRM systems, email marketing tools, and analytics software to interpret results. Preferably experience with Braze.
  • Extremely organized with an ability to prioritize and self-manage
  • Demonstrated success in loyalty strategies, retention, and sales growth
  • Experience developing efficient and effective end-to-end journey/campaign strategies
  • Familiarity with the health tech industry and knowledge of best practices and emerging trends in lifecycle marketing
  • Hypothesis-led and data-driven in all marketing intent. Comfort with numbers and analytics required.
  • Strong product skills, and the ability to understand and contribute to cross-functional discussion and planning around efforts to increase activation, reduce churn and improve conversion.
Responsibilities
  • Own and optimize lifecycle marketing strategies, including customer onboarding, engagement, retention, and reactivation across various channels such as email, SMS, customer portal, and other relevant touch points to deliver outcomes.
  • Oversee and execute end-to-end email marketing execution from briefing, copywriting, graphics, competitor analysis, audience list pull, email build, and deployment to email performance and metrics reporting.
  • Understand the brand positioning, writing punchy, on-brand email copy for timely execution.
  • Assist marketing leaders in developing a roadmap for customer segmentation, messaging, campaign management, and triggered communications throughout the customer lifecycle.
  • Collaborate with cross-functional teams to align lifecycle marketing initiatives with overall business objectives.
  • Oversee email marketing agency to develop, implement, and monitor triggered email journeys and promotional campaigns.
  • Work closely with marketing team members including copywriters, graphic designers, and cross-functional teams to support expedited implementation of email journeys.
  • Maintain an understanding of industry trends and best practices in CRM, loyalty, and e-commerce, and develop innovative strategies and campaigns to enhance customer experiences and increase revenue.
  • Work closely with Customer Experience team to ensure a best-in-class patient experience, creating and optimizing automated email journeys to increase conversions and drive customer retention.
  • Oversee CRM from a data-driven perspective, analyzing conversions, analytics, retention, optimizations, and testing opportunities.
  • Develop, implement, and monitor multichannel marketing campaigns across a range of customer lifecycle stages, including retention, nurture, prospect, and lead generation.
  • Implement strategies to increase customer retention and foster loyalty, such as loyalty programs, segmented communication strategies, and reward programs for repeat purchases.
  • Analyze areas of opportunity for strategic optimizations that will increase revenue, improve conversions, boost retention, and increase sales, while supporting the overall brand experience.
  • Provide analysis of key metrics as part of the evaluation, optimization, and benchmarking process, in partnership with cross-functional teams; generate and communicate meaningful insights to key stakeholders in order to assist them in making more informed and data-driven decisions.
  • Analyze customer data to identify opportunities for personalization, behavioral targeting, and interventions tailored to specific lifecycle stages.
  • Have a data-driven mindset to optimize underperforming and reiterate optimized email journeys to continuously improve performance across various lifecycle stages.

AgelessRx offers telehealth-based longevity care, providing access to prescription medications and therapies aimed at slowing aging and preventing age-related diseases. Its products include Metformin, Low Dose Naltrexone (LDN), NAD+ patches, and Galleri cancer screening, all available through a direct-to-consumer subscription model. Customers complete online consultations with healthcare professionals, receive prescriptions, and have treatments delivered to their homes. The company differentiates itself with science-backed treatment options, educational resources, and a portion of profits directed toward longevity research and advocacy, positioning itself to serve consumers seeking proactive health management. Its goal is to help people extend their healthspan by making preventative anti-aging care more accessible and by supporting scientific progress in longevity.

Company Size

51-200

Company Stage

N/A

Total Funding

$1

Headquarters

Ann Arbor, Michigan

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • 6,600 patients gained mental clarity; 8,300 boosted energy in 2025.
  • 5,200+ completed clinical studies on therapy efficacy.
  • 82.7% reported improvements by first check-in.

What critics are saying

  • FDA halts GLP-1 microdosing trial for unapproved anti-aging use.
  • Novo Nordisk undercuts prices, captures market in 18 months.
  • Adverse events from Rapamycin trigger lawsuits in 12 months.

What makes AgelessRx unique

  • Offers Rapamycin and microdosed GLP-1s via Stanford PhD-led trials.
  • Infinite Longevity Support targets all 9 aging hallmarks.
  • Provides 30+ diagnostics including NAD+ Nasal Spray.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

6%
Decrypt
May 2nd, 2025
Dementia Risk Tied To Biological Age In New Study

In brief The research showed that biological age can be a stronger predictor of dementia risk than chronological age.According to a February 2025 report by the National Institutes of Health, more than 6 million Americans are living with dementia.Experts say tracking biological age helps improve the understanding of health and aging, while also identifying early risks of diseases such as dementia.Decrypt’s Art, Fashion, and Entertainment Hub. Discover SCENEAging faster on the inside—even if you're still young on the outside—could raise your risk of dementia, a new study from Zhengzhou University in China found.The research showed that biological age, or how well the body is functioning, can be a stronger predictor of dementia risk than chronological age.The study, published on Wednesday in Neurology, the journal of the American Academy of Neurology, used data from the UK Biobank and tracked 280,918 people with an average age of 57 over a 14-year period.It found that faster biological aging was linked to a 14% to 15% higher risk of developing dementia.“With the rising impact of dementia around the world, identifying risk factors and implementing preventive measures is essential,” lead researcher Dr. Yacong Bo said. “While none of us can change our chronological age, we can influence our biological age through lifestyle factors such as diet and exercise.”To assess biological aging, Chinese researchers used two metrics: Klemera–Doubal Method Biological Age (KDM-BA), which uses blood test results; and PhenoAge, which draws on clinical data tied to aging and mortality.For each increase in the rate of biological aging, as measured by KDM-BA and PhenoAge, the risk of dementia rose."These brain structure changes explain some, but not all, of the association between advanced biological age and dementia," Bo continued. "These results support the hypothesis that advanced biological age may contribute to the development of dementia by causing a widespread change in brain structures."More than 6 million Americans are living with dementia, which causes about 100,000 deaths annually, according to a February 2025 report by the National Institutes of Health.While dementia has declined 13% per decade due to better education, heart health, and lifestyle, the total number of cases is rising as the population ages, increasing pressure on the healthcare system.In 2020, the number of people worldwide with dementia stood at 55 million, according to the non-profit Alzheimer’s Disease International. By 2030, the number is expected to reach 78 million, and by 2050, it is projected to reach 139 million.Age is often seen as just a number on a calendar, with chronological age referring to the number of years one has been alive

INACTIVE